• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Kura Oncology - Articles and news items


First patient dosed in Phase 2 study of tipifarnib in advanced cancers with HRAS mutations

Industry news / 18 May 2015 / Victoria White

The first patient has been dosed in the Phase 2 clinical trial of tipifarnib in patients with locally advanced tumours that carry HRAS mutations…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +